DOJ announced a nationwide healthcare fraud enforcement action charging 455 defendants in connection with more than $6.5 billion in alleged fraud. The announcement spans schemes involving healthcare fraud, opioid-related conduct, provider exclusions, and allegations of patient harm. It reflects the scale of federal enforcement and the legal risks facing providers, executives, and intermediaries across multiple parts of the healthcare system.